Pemphigoid gestationis: Difference between revisions
From IDWiki
(Imported from text file) |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
| Line 3: | Line 3: | ||
* 1 in 50,000 pregnancies |
* 1 in 50,000 pregnancies |
||
| − | == Clinical |
+ | == Clinical Manifestations == |
* Very itchy bullous or vesicular rash |
* Very itchy bullous or vesicular rash |
||
Revision as of 08:12, 14 July 2020
Epidemiology
- 1 in 50,000 pregnancies
Clinical Manifestations
- Very itchy bullous or vesicular rash
- Typically starts periumbilically and spreads
- Starts in the second half of pregnancy, may flare post-partum
Diagnosis
- Skin biopsy
Management
- Prednisolone 0.5 mg/kg/d into the postpartum period, then titrate down
- May flare post-partum
- Second-line is azathioprine
Prognosis and Complications
- 10% risk of neonatal pemphigoid
- Associated with other autoimmune disorders
